НовостиBenzingaUBS Initiates Coverage On Adarx Pharmaceuticals with Buy Rating, Announces Price Target of $35 UBS Initiates Coverage On Adarx Pharmaceuticals with Buy Rating, Announces Price Target of $35 Benzinga 2026.10.20 12:27 (GMT+0) Открыть на Benzinga Другие новости